These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 18635413)
1. Age influences the severity of Graves' ophthalmopathy. Lin MC; Hsu FM; Bee YS; Ger LP Kaohsiung J Med Sci; 2008 Jun; 24(6):283-8. PubMed ID: 18635413 [TBL] [Abstract][Full Text] [Related]
2. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [TBL] [Abstract][Full Text] [Related]
3. [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease]. Rink T; Holle LH; Schroth HJ; Garth H Nuklearmedizin; 1998 May; 37(3):90-4. PubMed ID: 9604228 [TBL] [Abstract][Full Text] [Related]
4. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy. Molnár I; Balázs C Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165 [TBL] [Abstract][Full Text] [Related]
6. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109 [TBL] [Abstract][Full Text] [Related]
7. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
8. Are porcine and human TSH receptor antibody measurements comparable? Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037 [TBL] [Abstract][Full Text] [Related]
9. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients. Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710 [TBL] [Abstract][Full Text] [Related]
10. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. Wakelkamp IM; Prummel MF; Wiersinga WM Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406 [TBL] [Abstract][Full Text] [Related]
11. Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis. Paunkovic J; Paunkovic N Horm Metab Res; 2006 Jan; 38(1):53-6. PubMed ID: 16477542 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy? Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277 [TBL] [Abstract][Full Text] [Related]
13. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease. Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915 [TBL] [Abstract][Full Text] [Related]
14. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Molnár I Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495 [TBL] [Abstract][Full Text] [Related]
15. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881 [TBL] [Abstract][Full Text] [Related]
16. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids. Bednarek J; Wysocki H; Sowiński J Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621 [TBL] [Abstract][Full Text] [Related]
17. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment. Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228 [TBL] [Abstract][Full Text] [Related]
18. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563 [TBL] [Abstract][Full Text] [Related]